--- title: "Pre-market hot trades in US stocks: Alibaba up 3.51% in pre-market; ASML up 3.41% in pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/278528056.md" description: "Alibaba pre-market up 3.51%; ASML pre-market up 3.41%; Biorestorative Therapies pre-market up 50.86%; Australian Oilseeds pre-market up 41.59%; MiNK Therapeutics pre-market up 38.76%" datetime: "2026-03-10T09:42:34.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278528056.md) - [en](https://longbridge.com/en/news/278528056.md) - [zh-HK](https://longbridge.com/zh-HK/news/278528056.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/278528056.md) | [繁體中文](https://longbridge.com/zh-HK/news/278528056.md) # Pre-market hot trades in US stocks: Alibaba up 3.51% in pre-market; ASML up 3.41% in pre-market **Pre-market Hot Trades in US Stocks** Alibaba pre-market rose by 3.51%. Based on recent key news: 1. On March 10, Alibaba announced that DingTalk would integrate with the AI platform OpenClaw, driving the stock price up. This move allows businesses and individual developers to access related services for free, boosting market confidence in Alibaba's AI business, with the stock price rising to HKD 133.8, an increase of 3.96%; Source: Zhitong Finance. 2. On March 10, Alibaba recorded large transactions, leading to a rise in stock price. On that day, Alibaba recorded multiple large transactions with a total transaction amount of HKD 183 million, pushing the stock price up to HKD 133.7, an increase of 3.89%; Source: Economic Information Agency. 3. On March 9, Citigroup maintained a buy rating on Alibaba with a target price of HKD 195. Citigroup expects Alibaba's third-quarter performance to meet expectations, with cloud revenue growth of 35%, supporting market confidence in Alibaba; Source: Citigroup report on geopolitical impacts on market volatility, requiring cautious response. ASML pre-market rose by 3.41%. Based on recent key news: 1. On March 8, ASML's 2025 annual report showed strong demand visibility, with growth in AI-driven semiconductor demand and continued investment in advanced lithography technology. The performance commitment increased from EUR 43 billion to EUR 46.5 billion, with an expected 65% to convert into revenue within the next 12 months, reinforcing the company's potential to reach the upper limit of expected revenue range. Source: Investing.com. 2. On March 9, ASML announced the appointment of former ASM International CEO Benjamin Loh as a member of the supervisory board, which may affect the company's governance structure. Source: Company announcement. 3. On March 7, export regulations and geopolitical pressures increased uncertainty regarding ASML's ability to deliver equipment to key markets, leading to market concerns about short-term returns. Source: Investing.com. The semiconductor industry is driven by AI demand, showing significant long-term growth potential. **Top Gainers in Pre-market US Stocks** Biorestorative Therapies, pre-market rose by 50.86%, with no significant news recently. Trading is active, with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Australian Oilseeds pre-market rose by 41.59%. Australian Oilseeds pre-market rose by 41.59%. No significant news recently; trading is active, with clear capital flow; considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no\_news MiNK Therapeutics pre-market rose by 38.76%. Based on recent key news: 1. On March 10, MiNK Therapeutics announced a collaboration with C-Further to advance PRAME-targeted TCR-modified iNKT cell therapy for pediatric cancer This collaboration will provide $1.1 million in funding for its IND support development and share subsequent commercial revenues. This news drove the stock price up. 2. On March 10, MiNK Therapeutics issued a statement emphasizing the potential and safety of its agenT-797 therapy, detailing the clinical trial design and timeline. This statement enhanced market confidence in the company's future development. 3. On March 9, MiNK Therapeutics mentioned its extensive development plans in a forward-looking statement, noting that despite risks and uncertainties, investors remain optimistic about its long-term growth potential. The biotechnology industry has performed strongly recently, with significant capital inflows ### Related Stocks - [Alibaba Group Holding Limited (BABA.US)](https://longbridge.com/en/quote/BABA.US.md) - [BABA-WR (89988.HK)](https://longbridge.com/en/quote/89988.HK.md) - [BABA-W (09988.HK)](https://longbridge.com/en/quote/09988.HK.md) - [ASML Holding N.V. (ASML.US)](https://longbridge.com/en/quote/ASML.US.md) - [Direxion Daily Semicondct Bull 3X ETF (SOXL.US)](https://longbridge.com/en/quote/SOXL.US.md) ## Related News & Research - [Alibaba, Bytedance And Tencent Are Turning To Domestic Chipmakers To Ease The Pain From A Deepening Global Shortage Of Memory Chips - The Information](https://longbridge.com/en/news/277949529.md) - [Kudelski Labs Security IP Powers Axelera AI’s Secure Europa Edge Chip](https://longbridge.com/en/news/278501706.md) - [Alibaba forms task force to boost AI development after Qwen chief's exit](https://longbridge.com/en/news/277877051.md) - [Head of Alibaba's Qwen AI division resigns](https://longbridge.com/en/news/277711975.md) - [Full Metal Jacket – The Rise of the Humanoid Robot Defenders](https://longbridge.com/en/news/278398173.md)